Literature DB >> 36261832

Effectiveness of letters to patients with or without Cochrane blogshots on 10-year cardiovascular risk change among women in menopausal transition: 6-month three-arm randomized controlled trial.

Slavica Jurić Petričević1, Ivan Buljan2, Dora Bjelanović3, Nataša Mrduljaš-Đujić4, Tanja Pekez5, Mario Ćurković6,7, Željko Vojvodić7,8, Ivančica Pavličević4, Matko Marušić9, Ana Marušić10.   

Abstract

BACKGROUND: Health information and patient education on lifestyle changes may have a positive effect on the prevention of many chronic conditions, especially cardiovascular diseases (CVDs). We performed a parallel, three-arm randomized controlled trial (RCT) of 6-month educational intervention in a form of letters containing a reminder of the participant's CVD risk with or without Cochrane blogshots to reduce CVD risk among women aged 45-65 with one or more known CVD risk factors.
METHODS: The control group received a letter about their CVD risk at the beginning of the trial. The intervention groups received the initial letter about their CVD risk and remainder letters about their CVD risk every 2 months, with or without Cochrane blogshots: (1) effect of calcium in the prevention of high blood pressure, (2) effect of reducing saturated fat acids in eating habits, and (3) effects of green and black tea in CVD prevention. The primary outcome was CVD risk reduction calculated as the difference between the baseline and 6-month score for a 10-year risk of fatal CVD according to the ACC/AHA guidelines.
RESULTS: After both interventions, CVD risk reduction was significantly higher compared to the control group (P < 0.001, Kruskal-Wallis H test). The number of participants who decreased their CV risk was 29% (20/70) in the control group, 69% (48/70) in the group receiving the reminder letters, and 70% (49/70) in the group receiving the reminder letters and blogshots. The number needed to treat to achieve risk reduction was 2.41 (95% CI = 1.77 to 3.78) for letters with a CVD risk reminder and 2.50 (1.81 to 4.03) for letters with a reminder and a blogshot. The group receiving reminder letters with Cochrane blogshots had a significant change in the category of CVD risk, mainly from high to moderate and from moderate to low CVD risk category.
CONCLUSIONS: A simple and inexpensive intervention method in a form of letters reminding women about their CVD risk with or without providing additional health information in the form of Cochrane blogshots about interventions for important CVD risk factors may be effective in CVD management and could be considered by primary care providers. TRIAL REGISTRATION: ClinicalTrials.gov, NCT04601558. Retrospectively registered on October 19, 2020.
© 2022. The Author(s).

Entities:  

Keywords:  CVD risk; Cochrane blogshots; Educational intervention; Women

Mesh:

Substances:

Year:  2022        PMID: 36261832      PMCID: PMC9583570          DOI: 10.1186/s12916-022-02555-2

Source DB:  PubMed          Journal:  BMC Med        ISSN: 1741-7015            Impact factor:   11.150


  34 in total

1.  The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe.

Authors:  S Sans; H Kesteloot; D Kromhout
Journal:  Eur Heart J       Date:  1997-12       Impact factor: 29.983

2.  Validation of a decisional conflict scale.

Authors:  A M O'Connor
Journal:  Med Decis Making       Date:  1995 Jan-Mar       Impact factor: 2.583

Review 3.  Cardiovascular Disease in Women: Clinical Perspectives.

Authors:  Mariana Garcia; Sharon L Mulvagh; C Noel Bairey Merz; Julie E Buring; JoAnn E Manson
Journal:  Circ Res       Date:  2016-04-15       Impact factor: 17.367

4.  National study of physician awareness and adherence to cardiovascular disease prevention guidelines.

Authors:  Lori Mosca; Allison H Linfante; Emelia J Benjamin; Kathy Berra; Sharonne N Hayes; Brian W Walsh; Rosalind P Fabunmi; Johnny Kwan; Thomas Mills; Susan Lee Simpson
Journal:  Circulation       Date:  2005-02-01       Impact factor: 29.690

Review 5.  Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials.

Authors:  Finlay A McAlister; Simon Stewart; Stefania Ferrua; John J J V McMurray
Journal:  J Am Coll Cardiol       Date:  2004-08-18       Impact factor: 24.094

Review 6.  Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysis.

Authors:  Xuanping Zhang; Heather M Devlin; Bryce Smith; Giuseppina Imperatore; William Thomas; Felipe Lobelo; Mohammed K Ali; Keri Norris; Stephanie Gruss; Barbara Bardenheier; Pyone Cho; Isabel Garcia de Quevedo; Uma Mudaliar; Christopher D Jones; Jeffrey M Durthaler; Jinan Saaddine; Linda S Geiss; Edward W Gregg
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

7.  Comparison of blogshots with plain language summaries of Cochrane systematic reviews: a qualitative study and randomized trial.

Authors:  Ivan Buljan; Ružica Tokalić; Marija Roguljić; Irena Zakarija-Grković; Davorka Vrdoljak; Petra Milić; Livia Puljak; Ana Marušić
Journal:  Trials       Date:  2020-05-25       Impact factor: 2.279

8.  Health status and self-management in patients with inflammatory arthritis-A five-year follow-up study after nurse-led patient education.

Authors:  Kjersti Grønning; Siriwan Lim; Ola Bratås
Journal:  Nurs Open       Date:  2019-10-08

9.  Implementing shared decision-making in nutrition clinical practice: a theory-based approach and feasibility study.

Authors:  Sophie Desroches; Marie-Pierre Gagnon; Sylvie Tapp; France Légaré
Journal:  Implement Sci       Date:  2008-11-05       Impact factor: 7.327

Review 10.  Impact of providing patients access to electronic health records on quality and safety of care: a systematic review and meta-analysis.

Authors:  Ana Luisa Neves; Lisa Freise; Liliana Laranjo; Alexander W Carter; Ara Darzi; Erik Mayer
Journal:  BMJ Qual Saf       Date:  2020-06-12       Impact factor: 7.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.